We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$1.33B
AUM Growth
+$32.7M
Cap. Flow
-$8.4M
Cap. Flow %
-0.63%
Top 10 Hldgs %
25.6%
Holding
269
New
11
Increased
67
Reduced
121
Closed
3

Top Sells

Rank Stock Value
1
MRSH
Marsh
MRSH
+$7.81M
2
ZBRA icon
Zebra Technologies
ZBRA
+$3.97M
3
AAPL icon
Apple
AAPL
+$1.98M
4
GIS icon
General Mills
GIS
+$1.56M
5
IDXX icon
Idexx Laboratories
IDXX
+$1.56M

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Healthcare 14.88%
3 Industrials 8.28%
4 Financials 8.11%
5 Consumer Discretionary 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
26
NextEra Energy
NEE
$177B
$15.4M 1.16%
204,014
+17,356
+9% +$1.35M
IJR icon
27
iShares Core S&P Small-Cap ETF
IJR
$112B
$15.2M 1.14%
135,732
-6,897
-5% -$722K
SYK icon
28
Stryker
SYK
$130B
$15.2M 1.14%
62,173
+244
+0.4% +$58.5K
VWO icon
29
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$15M 1.12%
286,358
-2,039
-0.7% -$109K
ROP icon
30
Roper Technologies
ROP
$39.8B
$13.8M 1.04%
34,303
+232
+0.7% +$93.1K
TEL icon
31
TE Connectivity
TEL
$62.6B
$13.8M 1.04%
107,314
+263
+0.2% +$33.8K
VCSH icon
32
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$13.7M 1.03%
168,713
+2,503
+2% +$207K
MKC icon
33
McCormick & Company Non-Voting
MKC
$14.2B
$13.4M 1%
147,088
-2,004
-1% -$178K
CRM icon
34
Salesforce
CRM
$158B
$13.1M 0.98%
62,340
+3,235
+5% +$720K
ABT icon
35
Abbott
ABT
$187B
$12.4M 0.93%
103,309
-210
-0.2% -$24.9K
CVS icon
36
CVS Health
CVS
$122B
$12.1M 0.91%
159,833
-2,039
-1% -$149K
PG icon
37
Procter & Gamble
PG
$339B
$12M 0.9%
84,105
-9,565
-10% -$1.25M
SPGI icon
38
S&P Global
SPGI
$120B
$11.1M 0.83%
34,438
+7,148
+26% +$2.38M
ADBE icon
39
Adobe
ADBE
$105B
$11M 0.82%
23,119
+614
+3% +$287K
FLOT icon
40
iShares Floating Rate Bond ETF
FLOT
$10.3B
$10.7M 0.8%
208,911
+14,041
+7% +$713K
DHR icon
41
Danaher
DHR
$144B
$10.6M 0.79%
52,383
-1,119
-2% -$227K
QQQ icon
42
Invesco QQQ Trust
QQQ
$484B
$10.6M 0.79%
33,111
-1,838
-5% -$588K
IDXX icon
43
Idexx Laboratories
IDXX
$46.2B
$10.4M 0.78%
20,559
-3,110
-13% -$1.56M
DLTR icon
44
Dollar Tree
DLTR
$25.2B
$10.2M 0.76%
88,472
-1,660
-2% -$178K
SEDG icon
45
SolarEdge
SEDG
$1.95B
$10.1M 0.76%
35,581
+1,074
+3% +$324K
PEP icon
46
PepsiCo
PEP
$190B
$9.99M 0.75%
66,988
-5,851
-8% -$803K
ABBV icon
47
AbbVie
ABBV
$435B
$9.75M 0.73%
89,979
-445
-0.5% -$47.6K
JPM icon
48
JPMorgan Chase
JPM
$950B
$9.69M 0.73%
63,659
-412
-0.6% -$59.3K
VTIP icon
49
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$8.93M 0.67%
175,438
+21,734
+14% +$1.12M
VZ icon
50
Verizon
VZ
$196B
$8.58M 0.64%
148,599
+504
+0.3% +$28.4K

Similar funds

Boston Family Office's Q1 2021 Portfolio in Review

As of Q1 2021, Boston Family Office held 269 positions worth $1.33B, up 2.5% from $1.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Boston Family Office's Q1 2021 filing shows 11 new, 67 increased, 121 reduced and 3 closed positions. Its largest new stake was JPMorgan Ultra-Short Municipal Income ETF: 24,793 shares worth $1.11M. The largest sale was Marsh, an estimated $7.81M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Family Office's largest Q1 2021 buy was JPMorgan Ultra-Short Municipal Income ETF: 24,793 shares worth $1.11M.
  • Boston Family Office added most to Sherwin-Williams in Q1 2021, an estimated $12.2M increase.
  • Boston Family Office's biggest Q1 2021 reduction was Marsh, cutting an estimated $7.81M.
  • Boston Family Office fully exited Valero Energy in Q1 2021, selling an estimated $259K.
  • Boston Family Office's ten largest holdings make up 26% of its $1.33B portfolio in Q1 2021.
  • Boston Family Office opened 11 new positions and closed 3 in Q1 2021.
  • Boston Family Office's portfolio value rose 2.5% quarter-over-quarter to $1.33B.

Based on Boston Family Office's 13F filing for Q1 2021, filed 7 May 2021.